Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Growing awareness of sleep health, non-invasive treatment adoption, and technological advancements accelerate global anti-snoring devices market growth.Austin, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ...

NEW YORK -- Technology is bringing relief to people who suffer from sleep apnea. Instead of a big, loud, clunky mask, a small implant in the chest is helping patients get a better night's sleep. Joe ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

The U.S. Food and Drug Administration approved Friday a new device that could help prevent sleep apnea and snoring — and it doesn't need to be worn at night. People who snore — and their partners — ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

LivaNova is poised to become Inspire Medical's first competitor in the United States with a fully implantable neurostimulation device for obstructive sleep apnea. London, England-based LivaNova ...

UC Davis Medical Center has become the first hospital in Northern California to treat patients with moderate to severe ...

For a potentially serious medical condition, it’s remarkable how few people know they have obstructive sleep apnea (OSA). The good news is that for people with a diagnosis, there have never been more ...